Streamlined and Standardised Endpoints: Adopting Quantitative Imaging and Digital Pathology in MASH and Obesity Trials

Time: 9:00 am
day: Conference Day 2 Morning

Details:

  • Understanding treatment response in MASH and its metabolic co-morbidities using quantitative multi-organ imaging and MRI body composition
  • Streamlining key primary and secondary endpoints in MASH and cirrhosis clinical trials through digital pathology and endoscopy central reads

Speakers: